References
- Kaneko Y., et al. Clinical effects of CS-522(captopril) in the treatment of essential hypertension. Igakuno-ayumi(in Japanese) 1982; 122: 62–85
- Kuramoto K. Safety of captopril in the collected cases in Japan. In ACE inhibitor in antihypertensive treatment. Medical Tribune, Tokyo 1985; 45–52
- Shionoiri H., Kaneko Y. Angiotensin converting enzyme inhibitors and the therapy of hypertension. Igakuno-ayumi(in Japanese) 1985; 133: 139–146
- Jenkins A. C., Dreslinski G. R., Tadros S. S., Groel J. T., Fand R., Herczeg S. A. Captopril in hypertension:seven years later. J. Cardiovasc, Pharmacol. 1985; 7: s96–sl01
- Hricik D. E., Browning P. J., Kopelmanm R., Groorno W. E., Madias N. E., Dzau V. J. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal artery stenosis in a solitary kidney. N. Engl. J. Med. 1983; 308: 373–376
- Hirakata H., et al. Worsening of anemia induced by long-term use of captopril in hemodialysis patients. Am. J. Nephrol. 1984; 4: 355–360
- Croog S. H., Levine S., Testa M. A., Brown B., Bulpitt C. J., Jenkins C. D., Klerman G. L., Williams G. H. The effects of antihypertensive therapy on the quality of life. N. Engl. J. Med. 1986; 314: 1657–1664